{"DataElement":{"publicId":"4573660","version":"1","preferredName":"Investigational Medical Device Investigational New Drug Participation Within 4 Week First Dose Treatment Regimen Occurrence Yes No Indicator","preferredDefinition":"Text term to signify whether a patient is currently participating in or has participated in an investigational new drug or investigational medical device study within 4 weeks of the first dose of a treatment regimen.","longName":"DEV_IND_PT_4WK_YNIND","context":"CITN","contextVersion":"1","DataElementConcept":{"publicId":"4573659","version":"1","preferredName":"Investigational Medical Device Investigational New Drug Participation Within 4 Week First Dose Treatment Regimen Occurrence","preferredDefinition":"A device that is the subject of clinical investigation or research to determine the safety or effectiveness of the device. Investigational devices include transitional devices (21 CFR 812.3(r)) that are objects of investigations. An investigational device may be an approved device that is being studied for an unapproved use or efficacy._A new drug or biological drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes._A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._The act of taking part in an activity._Preceding all others in time or space or degree._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._A treatment plan that specifies the dosage, the schedule, and the duration of treatment._An instance of something happening, such as an event or incident","longName":"4573656v1.0:4573657v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"4573656","version":"1","preferredName":"Investigational Medical Device Investigational New Drug Participation","preferredDefinition":"A device that is the subject of clinical investigation or research to determine the safety or effectiveness of the device. Investigational devices include transitional devices (21 CFR 812.3(r)) that are objects of investigations. An investigational device may be an approved device that is being studied for an unapproved use or efficacy.:A new drug or biological drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes.:The act of taking part in an activity.","longName":"C72968:C49135:C25608","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Investigational Medical Device","conceptCode":"C72968","definition":"A device that is the subject of clinical investigation or research to determine the safety or effectiveness of the device. Investigational devices include transitional devices (21 CFR 812.3(r)) that are objects of investigations. An investigational device may be an approved device that is being studied for an unapproved use or efficacy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Investigational New Drug","conceptCode":"C49135","definition":"A new drug or biological drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Participation","conceptCode":"C25608","definition":"The act of taking part in an activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"071E04E1-F225-C83E-E050-BB89AD435EC1","latestVersionIndicator":"Yes","beginDate":"2014-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-05","modifiedBy":"ONEDATA","dateModified":"2014-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4573657","version":"1","preferredName":"Within Integer::4 Week First Dose Treatment Regimen Occurrence","preferredDefinition":"On the inside; contained in.:A number with no fractional part, including the negative and positive numbers as well as zero.::4:Any period of seven consecutive days.:Preceding all others in time or space or degree.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:A treatment plan that specifies the dosage, the schedule, and the duration of treatment.:An instance of something happening, such as an event or incident.","longName":"4573657v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Treatment Regimen","conceptCode":"C15697","definition":"A treatment plan that specifies the dosage, the schedule, and the duration of treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"071E04E1-F23B-C83E-E050-BB89AD435EC1","latestVersionIndicator":"Yes","beginDate":"2014-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-05","modifiedBy":"ONEDATA","dateModified":"2014-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"071E04E1-F24C-C83E-E050-BB89AD435EC1","latestVersionIndicator":"Yes","beginDate":"2014-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"4/18/16 Released, used in CITN-10. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5999742","version":"1","longName":"CRF CDEs","context":"CITN","ClassificationSchemeItems":[{"publicId":"5999747","version":"1","longName":"Eligibility CDEs","context":"CITN"}]}],"AlternateNames":[{"name":"DEV_IND_PT_4WK_YNIND","type":"USED_BY","context":"CITN"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Is currently participating in","type":"Preferred Question Text","description":"Is currently participating in or has participated in a study of an investigational agent or using an investigational device within 4 weeks of the first dose of treatment","url":null,"context":"CITN"},{"name":"NRG_CRF_Text 1","type":"Alternate Question Text","description":"Participation in any investigational drug study (excluding non-oncology and/or symptom management studies) within 4 weeks prior to registration","url":null,"context":"NRG"},{"name":"CITN-1","type":"Alternate Question Text","description":"Patient has received an investigational agent or have used an investigational device within 4 weeks of the first dose of study drug.","url":null,"context":"CITN"},{"name":"NRG_CRF_TEXT2","type":"Alternate Question Text","description":"Is the patient planning to receive any other investigational agents during the course of protocol therapy?","url":null,"context":"NRG"},{"name":"NRG_CRF_TEXT_3","type":"Alternate Question Text","description":"Participation in any investigational drug study for the treatment of cancer within 4 weeks prior to registration?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"071E04E1-F25E-C83E-E050-BB89AD435EC1","latestVersionIndicator":"Yes","beginDate":"2014-11-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-05","modifiedBy":"SERIANNJ","dateModified":"2021-04-26","changeDescription":"4/15/16 Released, used in CITN-10. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}